DK0432117T3 - Farmaceutisk præparat til behandling af inflammation - Google Patents

Farmaceutisk præparat til behandling af inflammation

Info

Publication number
DK0432117T3
DK0432117T3 DK90850286.7T DK90850286T DK0432117T3 DK 0432117 T3 DK0432117 T3 DK 0432117T3 DK 90850286 T DK90850286 T DK 90850286T DK 0432117 T3 DK0432117 T3 DK 0432117T3
Authority
DK
Denmark
Prior art keywords
inflammation
treatment
pharmaceutical preparation
antichymotrypsin
fowl
Prior art date
Application number
DK90850286.7T
Other languages
English (en)
Inventor
John Lezdey
Allan Wachter
Original Assignee
John Lezdey
Allan Wachter
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by John Lezdey, Allan Wachter filed Critical John Lezdey
Application granted granted Critical
Publication of DK0432117T3 publication Critical patent/DK0432117T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
DK90850286.7T 1989-12-04 1990-08-29 Farmaceutisk præparat til behandling af inflammation DK0432117T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/445,005 US5008242A (en) 1986-12-24 1989-12-04 Treatment of inflammation using 1-antichymotrypsin

Publications (1)

Publication Number Publication Date
DK0432117T3 true DK0432117T3 (da) 1994-07-25

Family

ID=23767272

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90850286.7T DK0432117T3 (da) 1989-12-04 1990-08-29 Farmaceutisk præparat til behandling af inflammation

Country Status (8)

Country Link
US (1) US5008242A (da)
EP (1) EP0432117B1 (da)
JP (1) JPH03181422A (da)
AT (1) ATE107515T1 (da)
CA (1) CA2019974C (da)
DE (1) DE69010162T2 (da)
DK (1) DK0432117T3 (da)
ES (1) ES2055406T3 (da)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5166134A (en) * 1986-12-24 1992-11-24 John Lezdey Treatment of allergic rhinitis
US5093316A (en) * 1986-12-24 1992-03-03 John Lezdey Treatment of inflammation
US5217951A (en) * 1986-12-24 1993-06-08 John Lezdey Treatment of inflammation
US5723316A (en) * 1989-06-23 1998-03-03 Trustees Of The University Of Pennsylvania α-1-antichymotrypsin analogues having chymase inhibiting activity
US5674708A (en) * 1989-06-23 1997-10-07 Trustees Of The University Of Pennsylvania α-1-antichymotrypsin analogues having elastase inhibitory activity
ATE146970T1 (de) * 1990-10-16 1997-01-15 John Lezdey Behandlung von entzündungen
JPH067191A (ja) * 1991-09-26 1994-01-18 Konica Corp モノクローナル抗体、それを産生するハイブリド−マ、その対応抗原及びそれを用いた測定方法
US5422244A (en) * 1992-05-05 1995-06-06 Athena Neurosciences, Inc. Detection of brain α1-antichymotrypsin
US5346886A (en) * 1993-11-15 1994-09-13 John Lezdey Topical α-1-antitrypsin, non-aqueous lipid miscible, benzalkonium chloride compositions for treating skin
GB2318732A (en) 1996-11-01 1998-05-06 Johnson & Johnson Medical Wound healing compositions containing alpha-1-antitrypsin
EP0898962A1 (en) * 1997-08-28 1999-03-03 Becton, Dickinson and Company Transdermal patches and methods for inactivating skin proteases
US6849605B1 (en) * 1999-03-05 2005-02-01 The Trustees Of University Technology Corporation Inhibitors of serine protease activity, methods and compositions for treatment of viral infections
US7247704B2 (en) 2000-12-18 2007-07-24 Arriva Pharmaceuticals, Inc. Multifunctional protease inhibitors and their use in treatment of disease
ES2239715T3 (es) * 2001-04-30 2005-10-01 Switch Biotech Aktiengesellschaft Utilizacion de la alfa-1 quimotripsina en la preparacion de una composicion para el tratamiento, prevencion o diagnostico de las heridas de dificil cicatrizacion causadas por la diabetes.
DE10121255A1 (de) 2001-04-30 2002-11-07 Switch Biotech Ag Verwendung von alpha 1-Antichymotrypsin Polypeptiden oder diese kodierende Nukleinsäuren, oder einer ein ACT Polypeptid oder diese kodierende Nukleinsäure exprimierende Zelle, zur Behandlung und/oder Prävention von diabetes-assoziierten und/oder arteriellen schlecht heilenden Wunden und zur Identifizierung von pharmakologisch aktiven Substanzen
WO2004052236A2 (en) * 2002-12-06 2004-06-24 Arriva Pharmaceuticals, Inc. Methods and compositions for treatment of otitis media
US20050031652A1 (en) * 2003-02-25 2005-02-10 Allergan, Inc. Compositions and methods comprising memantine and polyanionic polymers
DK2520654T3 (da) 2003-08-26 2017-05-01 Univ Colorado Regents Inhibitorer for serinproteaseaktivitet og disses anvendelse i fremgangsmåder og sammensætninger til behandling af bakterielle infektioner
US7217690B2 (en) 2003-10-07 2007-05-15 Kimberly-Clark Worldwide, Inc. Compositions of sunflower trypsin inhibitors
US7914771B2 (en) * 2004-03-09 2011-03-29 Arriva Pharmaceuticals, Inc. Treatment of chronic obstructive pulmonary disease by low dose inhalation of protease inhibitor
WO2010025314A2 (en) * 2008-08-28 2010-03-04 The General Hospital Corporation Prevention and treatment of itch with cysteine protease inhibition
EP3628327A1 (en) 2011-06-24 2020-04-01 The Regents of the University of Colorado, A Body Corporate Compositions, methods and uses for alpha-1 antitrypsin fusion molecules
KR20140137347A (ko) 2012-01-10 2014-12-02 더 리젠츠 오브 더 유니버시티 오브 콜로라도, 어 바디 코포레이트 알파-1 안티트립신 융합 분자용 조성물, 방법 및 용도
US10426815B2 (en) 2015-01-20 2019-10-01 The General Hospital Corporation Prevention and treatment of itch with an MRGPR antagonist
WO2021020509A1 (ja) * 2019-07-31 2021-02-04 株式会社ステムリム 間葉系幹細胞の増殖促進または減少抑制のための組成物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4117113A (en) * 1974-06-25 1978-09-26 National Research Development Corporation Immunological preparations
FR2374910A1 (fr) * 1976-10-23 1978-07-21 Choay Sa Preparation a base d'heparine, comprenant des liposomes, procede pour l'obtenir et medicaments contenant de telles preparations
US4356167A (en) * 1978-01-27 1982-10-26 Sandoz, Inc. Liposome drug delivery systems
US4829052A (en) * 1986-06-11 1989-05-09 Monsanto Company Serine protease inhibitors
US4916117A (en) * 1986-12-24 1990-04-10 John Lezdey Treatment of inflammation using alpha 1-antichymotrypsin

Also Published As

Publication number Publication date
ES2055406T3 (es) 1994-08-16
US5008242A (en) 1991-04-16
EP0432117A1 (en) 1991-06-12
DE69010162T2 (de) 1994-10-06
CA2019974C (en) 2002-01-22
JPH03181422A (ja) 1991-08-07
DE69010162D1 (de) 1994-07-28
ATE107515T1 (de) 1994-07-15
CA2019974A1 (en) 1991-06-04
EP0432117B1 (en) 1994-06-22

Similar Documents

Publication Publication Date Title
ATE107515T1 (de) Zusammensetzung zur behandlung von entzündung.
DE69019716D1 (de) Medizinisches Gerät zur Laserbehandlung.
LT2063B (lt) Guanino dariniu arba ju farmaceutiskai tinkamu drusku gavimo budas
FI871741A7 (fi) Valonsäteiden säteilyttämislaite käytettäväksi iensairauksien oraaliseen lääkintään.
FR2655534B1 (fr) Implant dentaire.
NO875022D0 (no) Apparat for medisinsk diagnostisering.
BR8804161A (pt) Composicao aperfeicoada esterilizavel por radiacao
DE68910799D1 (de) Faserbehandlungszusammensetzung.
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
DK376188D0 (da) Farmaceutisk dosisenhed
DK561089D0 (da) Anvendelse af lactamimider til fremstilling af laegemidler
DE68913088D1 (de) Faserbehandlungszusammensetzung.
FI881879A7 (fi) Valonsäteiden säteilyttämislaite lääketieteelliseen käyttöön.
DE58903964D1 (de) Fluessige orale formulierung.
BR9007070A (pt) Vacina para o tratamento preventivo de infeccao por vermes trematoides do figado em ruminantes
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
DE69023459D1 (de) Behandlung von pulmonarer Disfunktion mit 15-Keto-prostaglandin-Derivaten.
ES2019634B3 (es) Terapia con clorfeniramina.
FI875325A7 (fi) Näkyvänvalonsäteilyttäjälaite lääketieteelliseen käyttöön.
DE69003722D1 (de) Zahnärztliches Handstück.
ES2016785A4 (es) Instalaciones automaticas para tratamiento termico.
ES1005582Y (es) Esterilizador para odontologia.
ES1010920Y (es) Depuradora perfeccionado.
ES1006811Y (es) Camilla perfeccionada para tratamientos de magnetoterapia.
FI892375A0 (fi) Med penna manoevrerad anordning som ersaetter tangentbord.